Lexaria Bioscience Corp. (LEXX) stock
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.28+0.10 (+2.39%)
Close on Nov 18, 2026Market cap $106.09MP/E –Yield –
Lexaria Bioscience price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Lexaria Bioscience's price to book ratio was 24.3× on Nov 11, 2026, against 107.0× a year earlier. Over the last 5 years it ranged from 13.1× to 150.0×, with a median of 42.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 24.3× | −36.3 |
| 2025 | Dec 31, 2025 | 60.5× | −16.1 |
| 2024 | Dec 31, 2024 | 76.7× | +26.8 |
| 2023 | Dec 29, 2023 | 49.8× | +22.2 |
| 2022 | Dec 30, 2022 | 27.6× | +1.1 |
| 2021 | Dec 31, 2021 | 26.5× | −109.2 |
| 2020 | Dec 31, 2020 | 135.7× | −45.8 |
| 2019 | Dec 31, 2019 | 181.5× | −259.7 |
| 2018 | Dec 31, 2018 | 441.2× | +139.1 |
| 2017 | Nov 30, 2017 | 302.1× | – |
See a number that looks wrong?